Patents by Inventor Mark D. McKee

Mark D. McKee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VELIPARIB IN COMBINATION WITH CARBOPLATIN AND PACLITAXEL FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN SMOKERS
    Publication number: 20170172985
    Abstract: This invention pertains to a method for the treatment of non-small cell lung cancer in a subject who is a smoker, comprising administering to the subject an effective amount of 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (veliparib or ABT-888), or a pharmaceutically acceptable salt thereof, in combination with carboplatin and paclitaxel.
    Type: Application
    Filed: March 6, 2017
    Publication date: June 22, 2017
    Inventors: Vincent Giranda, Gary Gordon, Mark D. McKee, Jane Qian, Qin Qin
  • Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers
    Patent number: 9623009
    Abstract: This invention pertains to a method for the treatment of non-small cell lung cancer in a subject who is a smoker, comprising administering to the subject an effective amount of 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (veliparib or ABT-888), or a pharmaceutically acceptable salt thereof, in combination with carboplatin and paclitaxel.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: April 18, 2017
    Assignee: AbbVie, Inc.
    Inventors: Vincent Giranda, Gary Gordon, Mark D. McKee, Jane Qian, Qin Qin
  • VELIPARIB IN COMBINATION WITH CARBOPLATIN AND PACLITAXEL FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN SMOKERS
    Publication number: 20160074368
    Abstract: This invention pertains to a method for the treatment of non-small cell lung cancer in a subject who is a smoker, comprising administering to the subject an effective amount of 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (veliparib or ABT-888), or a pharmaceutically acceptable salt thereof, in combination with carboplatin and paclitaxel.
    Type: Application
    Filed: September 16, 2015
    Publication date: March 17, 2016
    Applicant: AbbVie Inc.
    Inventors: Vincent Giranda, Gary Gordon, Mark D. McKee, Jane Qian, Qin Qin